FindTrial
Sign In

The application of the integrated diagnosis and treatment model in Patients with prostate cancer

The application of the integrated diagnosis and treatment model in Patients with prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104883
Enrollment
Unknown
Registered
2025-06-25
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Control group:The traditional mode of diagnosis and treatment is adopted, that is, prostate biopsy is performed on patients, and radical prostatectomy is performed on patients with prostate cancer ind
Experimental group:The integrated diagnosis and treatment model is adopted, that is, the patient is biopsied with a prostate needle, and the resulting tissue is examined by rapid frozen section, and i

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Prostate-specific antigen (PSA) >10ng/ml; 2. Prostate Imaging Reporting and Data System (PI-RADS) score >=4 points; 3. Imaging examination showed localized prostate cancer.

Exclusion criteria

Exclusion criteria: 1. Previous diagnosis of prostate adenocarcinoma; 2. Imaging examination showed distant metastasis of prostate cancer or lymph node metastasis; 3. Previous history of benign prostatic hyperplasia surgery.

Design outcomes

Primary

MeasureTime frame
Time of operation;Peroperative bleeding;Hospital stays;Number of admissions;Psychological burden score;—

Countries

China

Contacts

Public ContactXuefei Ding

Northern Jiangsu People's Hospital

xuefeid@126.com+86 180 5106 1234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026